Sign in

CIK 0000744218 · Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
133191702
Phone
908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 8-K Event Executive or director change · Shareholder vote results
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. ARS Other Annual Report to Security Holders
  19. DEF 14A Proxy Proxy Statement
  20. 424B5 Offering Prospectus

Page 2 of 65 · 1,298 filings